United States · FDA National Drug Code directory
bupropion Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-918_c1d5cac6-7ca2-4b55-90c3-5ef51df0a1ee
- Product NDC
- 69097-918
- Form
- TABLET
- Composition / generic term
- bupropion Hydrochloride
- Labeler
- CIPLA USA INC.,
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180526
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (69097-918-02) · 69097-918-02
- 100 TABLET in 1 BOTTLE (69097-918-07) · 69097-918-07
- 1000 TABLET in 1 BOTTLE (69097-918-15) · 69097-918-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →